C
Culture Biosciences
Culture Robotics builds automated tools for fermentation
About Culture Biosciences
Culture Biosciences is a biotechnology startup that operates in the field of large-scale biomanufacturing. The company's primary service is to design, monitor, and analyze high-throughput bioprocessing experiments for its clients. This is done remotely using Culture's integrated bioreactor platform, a system that allows for the cultivation of cells in a controlled environment.
The company's clients are typically other businesses in the biotechnology sector, such as Joyn Bio and Modern Meadow, who require large-scale biomanufacturing capabilities. These clients benefit from Culture's services by being able to scale down their processes, as evidenced by the company's white paper on technical transfer.
Culture Biosciences operates in the biotechnology market, a sector that is seeing increasing demand for large-scale biomanufacturing solutions. The company recently announced its Series B financing, indicating a positive response from investors and a potential for growth.
The business model of Culture Biosciences is service-based. The company makes money by providing bioprocessing experiment services to its clients. This includes the design, monitoring, and analysis of these experiments, which are conducted on the company's integrated bioreactor platform.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 80
- Open positions
- 2
- Dealroom signal
- 74.6/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Industrial Automation, Biotechnology, Synthetic Biology, Spinout, Tech for Biotech and Pharma, YC W18, DT and LS
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Dec 2025 | — | — | Cultivian Sandbox Ventures · Northpond Ventures · Synthesis Capital | ↗ |
| SERIES BOther financing | Oct 2021 | $80M | $320M | BoxGroup · Section 32 · Verily · Northpond Ventures | — |
Growth signals
Latest recorded traffic for Culture Biosciences is 7.8K monthly website visits, down 67.5% over the last three months. Culture Biosciences's team declined 1.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Culture Biosciences in the San Francisco ecosystem
The Culture Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
US National Science Foundation
Wei Guo
Y Combinator
UpHonest Capital
Series A11 investors entered at this stage
Section 32
Ben Davenport
Refactor Capital
Cultivian Sandbox Ventures
Verily
E14 Fund
The Production Board
Northpond Ventures
BoxGroup
Craft Ventures
Synthesis Capital
Other known investors1 additional known investor
MIT Media Lab
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Culture Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Culture Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









